ZA201401636B - Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator - Google Patents

Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator

Info

Publication number
ZA201401636B
ZA201401636B ZA2014/01636A ZA201401636A ZA201401636B ZA 201401636 B ZA201401636 B ZA 201401636B ZA 2014/01636 A ZA2014/01636 A ZA 2014/01636A ZA 201401636 A ZA201401636 A ZA 201401636A ZA 201401636 B ZA201401636 B ZA 201401636B
Authority
ZA
South Africa
Prior art keywords
solvates
acid addition
addition salts
oxalic acid
estrogen receptor
Prior art date
Application number
ZA2014/01636A
Other languages
English (en)
Inventor
Srinivas Laxminarayan Pathi
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Chandrasekaran Ramasubbu
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201401636B publication Critical patent/ZA201401636B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2014/01636A 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator ZA201401636B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN665MU2013 IN2013MU00665A (pm) 2013-03-05 2014-03-05

Publications (1)

Publication Number Publication Date
ZA201401636B true ZA201401636B (en) 2014-11-26

Family

ID=50382470

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/01636A ZA201401636B (en) 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator

Country Status (3)

Country Link
IN (1) IN2013MU00665A (pm)
WO (1) WO2014135834A1 (pm)
ZA (1) ZA201401636B (pm)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018521988A (ja) 2015-06-16 2018-08-09 ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． ピペリジン誘導体およびその製造方法および医薬用途
BR112018011817A2 (pt) 2015-12-22 2018-12-04 Jiangsu Hengrui Medicine Co derivado de benzopiperidina, método de preparação do mesmo, e uso médico do mesmo
MX2022008091A (es) 2020-01-10 2022-07-11 Jiangsu Hengrui Medicine Co Derivado de tetrahidroisoquinolina triciclica, metodo de preparacion del mismo y aplicacion del mismo en medicina.
AU2022307207A1 (en) 2021-07-09 2024-02-15 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Salt types of tricyclic tetrahydro isoquinoline derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
CO4410190A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
JP2001523252A (ja) 1997-04-30 2001-11-20 イーライ・リリー・アンド・カンパニー 置換ベンゾ［ｂ］チオフェンの位置選択的アルキル化製造法
US7964734B2 (en) 2002-09-30 2011-06-21 A/S Gea Farmaceutisk Fabrik Raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
SI2032521T1 (sl) * 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
US8344149B2 (en) * 2006-10-17 2013-01-01 Cipla Limited Crystalline form of benzothiophene compound and process for preparation thereof
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy

Also Published As

Publication number Publication date
IN2013MU00665A (pm) 2015-07-03
WO2014135834A8 (en) 2014-11-27
WO2014135834A1 (en) 2014-09-12

Similar Documents

Publication Publication Date Title
IL281240A (en) Androgen receptor modulator and uses
IL275413A (en) Crystal forms of an androgen receptor modulator
IL242611B (en) Estrogen receptor modulator and uses thereof
GB201315630D0 (en) Shuttering system
SG11201600178TA (en) Pouring device
IL240019A0 (en) Estrogen receptor inhibitors
GB2529102B (en) Improved printing of security devices
PL2895287T3 (pl) Kombinacja materiałów dla urządzeń do dozowania rtęci oraz urządzenia zawierające wspomnianą kombinację materiałów
ZA201401636B (en) Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
GB2512882B (en) Formwork system
IL244418B (en) Liver X receptor modulators (lrx)
IL244412A0 (en) Liver X receptor modulators (lrx)
IL249160A0 (en) Crystal forms of an estrogen receptor modulator
TH1401007292A (th) รูปแบบผลึกของแอนโดรเจนรีเซปเตอร์มอดูเลเตอร์